Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Interactions of Psychiatric and COVID-19 Medications
Niayesh Mohebbi, Ali Talebi, Marjan Moghadamnia, et al.
Basic and Clinical Neuroscience Journal (2020)
Open Access | Times Cited: 23

Showing 23 citing articles:

The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial
Zhifen Liu, Dan Qiao, Yifan Xu, et al.
Journal of Medical Internet Research (2021) Vol. 23, Iss. 5, pp. e26883-e26883
Open Access | Times Cited: 146
A meta-analysis: The mortality and severity of COVID-19 among patients with mental disorders
Ahmad A. Toubasi, Rand Bilal AbuAnzeh, Hind B. Abu Tawileh, et al.
Psychiatry Research (2021) Vol. 299, pp. 113856-113856
Open Access | Times Cited: 135
Disaster management of the psychological impact of the COVID-19 pandemic
Mohamud Sheek‐Hussein, Fikri M. Abu‐Zidan, Émmanuel Stip
International Journal of Emergency Medicine (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 78
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development
Vincenzo Lionetti, Sveva Bollini, Raffaele Coppini, et al.
Pharmacological Research (2021) Vol. 168, pp. 105581-105581
Open Access | Times Cited: 35
Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude
Lei‐Yun Wang, Jiajia Cui, Qianying Ouyang, et al.
The EPMA Journal (2021) Vol. 12, Iss. 3, pp. 307-324
Open Access | Times Cited: 16
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health
Benedetta Vai, Mario Gennaro Mazza, Marisa Casanova Dias, et al.
European Psychiatry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 12
Drug–Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications
Giulio Di Mizio, Gianmarco Marcianò, Caterina Palleria, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 24, pp. 12936-12936
Open Access | Times Cited: 13
Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
Marios Spanakis, Πέτρος Ιωάννου, Sotiris Tzalis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7172-7172
Open Access | Times Cited: 9
SARS-CoV-2 Treatment: Current Therapeutic Options and the Pursuit of Tailored Therapy
Gianmarco Marcianò, Roberta Roberti, Caterina Palleria, et al.
Applied Sciences (2021) Vol. 11, Iss. 16, pp. 7457-7457
Open Access | Times Cited: 12
Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex
Thammarat Aree
Pharmaceuticals (2022) Vol. 15, Iss. 1, pp. 98-98
Open Access | Times Cited: 8
Drug-Drug Interactions Between COVID-19 Treatments and Psychotropic Medications: An Updated Study
Ujwal Boppana, Thomas S Leonard, Ayodeji Jolayemi, et al.
Cureus (2023)
Open Access | Times Cited: 4
Report of the Academy of Consultation-Liaison Psychiatry Task Force on Lessons Learned From the COVID-19 Pandemic: Executive Summary
Peter A. Shapiro, Khyati Brahmbhatt, Rachel A. Caravella, et al.
Journal of the Academy of Consultation-Liaison Psychiatry (2021) Vol. 62, Iss. 4, pp. 377-386
Open Access | Times Cited: 10
Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications.
Parisa Ghasemiyeh, Negar Mortazavi, Iman Karimzadeh, et al.
PubMed (2021) Vol. 20, Iss. 3, pp. 66-77
Closed Access | Times Cited: 6
Psychotropics and COVID-19: An analysis of safety and prophylaxis
Hervé Javelot, Céline Straczek, G. Meyer, et al.
L Encéphale (2021) Vol. 47, Iss. 6, pp. 564-588
Open Access | Times Cited: 4
Association between SARS-CoV-2 Infection and Neuropsychiatric Manifestations
Aranza Llorente Vidrio, Humberto Nicolini, Carlos Alfonso Tovilla‐Zárate, et al.
COVID (2022) Vol. 2, Iss. 9, pp. 1270-1286
Open Access | Times Cited: 3
Drug-drug interactions between COVID-19 therapeutics and psychotropic medications
Alessandro Cuomo, G. Barillà, Gianluca Serafini, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 925-936
Closed Access | Times Cited: 1
The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial (Preprint)
Zhifen Liu, Dan Qiao, Yifan Xu, et al.
(2021)
Open Access | Times Cited: 3
CHALLENGES REGARDING THE INTERACTION BETWEEN PSYCHOTROPICS AND COVID-19 CO-MEDICATION
CĂTĂLINA-ANGELA CRIȘAN
FARMACIA (2022) Vol. 70, Iss. 3, pp. 386-390
Open Access | Times Cited: 2
Senna makki and other active phytochemicals: Myths and realities behind covid19 therapeutic interventions
Naila Zaman, Nousheen Parvaiz, Rabia Farid, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0268454-e0268454
Open Access | Times Cited: 1
Letter on: “Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population”
Ahmad A. Toubasi
Schizophrenia Research (2021) Vol. 233, pp. 97-98
Open Access | Times Cited: 1
Rational Approach to Psychotropic Use in COVID-19 Cases With Psychiatric Comorbidities: Lesson Learnt From a Case Series
Jigyansa Ipsita Pattnaik, Sudipta Das, Hemlata Sarkar, et al.
Indian Journal of Psychological Medicine (2021) Vol. 43, Iss. 6, pp. 542-545
Open Access | Times Cited: 1
Efectos adversos severos de los estabilizadores del ánimo: revisión de la literatura
Álvaro Vallejos Narváez, José Busaid, Jhonatan Niño, et al.
Revista Colombiana de Ciencias Químico Farmacéuticas (2022) Vol. 51, Iss. 2
Open Access
Drug interactions associated with psychotropic medication and COVID-19
Valentin Oprea, Nicolae Bacinschi, Anastasia Caracaş
Bulletin of Integrative Psychiatry (2021) Vol. 89, Iss. 2, pp. 51-58
Open Access
Page 1

Scroll to top